Author

Timothy J. Bensman

Observed names: Bensman, Timothy Jay (author), T. Bensman, Tim Bensman, Timothy Bensman, Timothy J Bensman

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research

Observed institutions: University of Southern California, United States Food and Drug Administration, Center for Drug Evaluation and Research, The Ohio State University

OpenAlex ID: A5039255585

Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation

2021 · Kirk Chan-Tack, Patrick Harrington, et al. · Antiviral Research · 81

Bacterial Peptide Recognition and Immune Activation Facilitated by Human Peptide Transporter PEPT2

2008 · Peter W. Swaan, Timothy Bensman, et al. · American Journal of Respiratory Cell and Molecular Biology · 70

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis

2017 · Timothy J. Bensman, Joshua Wang, et al. · Antimicrobial Agents and Chemotherapy · 50

Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment

2017 · Jordanna G. Jayne, Timothy J. Bensman, et al. · American Journal of Respiratory Cell and Molecular Biology · 29

Rhesus θ-defensin-1 (RTD-1) exhibitsin vitroandin vivoactivity against cystic fibrosis strains ofPseudomonas aeruginosa

2015 · Paul M. Beringer, Timothy J. Bensman, et al. · Journal of Antimicrobial Chemotherapy · 29

PDF

Discovery of Novel CXCR2 Inhibitors Using Ligand-Based Pharmacophore Models

2015 · Helen Ha, Bikash Debnath, et al. · Journal of Chemical Information and Modeling · 27

Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation

2017 · Timothy J. Bensman, Jordanna G. Jayne, et al. · Antimicrobial Agents and Chemotherapy · 26

PDF

Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults

2024 · Heidi L Smith, Timothy J Bensman, et al. · The Journal of Infectious Diseases · 19

PDF

Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases

2023 · Jason N Moore, Lucas Poon, et al. · Journal of Antimicrobial Chemotherapy · 14

Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cells

2012 · Timothy J. Bensman, Albert N. Nguyen, et al. · Pulmonary Pharmacology & Therapeutics · 13

A novel phenylcyclohex‐1‐enecarbothioamide derivative inhibits CXCL8 ‐mediated chemotaxis through selective regulation of CXCR2 ‐mediated signalling

2013 · Helen Ha, Tim Bensman, et al. · British Journal of Pharmacology · 12

PDF

Anti-Inflammatory Effects of RTD-1 in a Murine Model of Chronic Pseudomonas aeruginosa Lung Infection: Inhibition of NF-κB, Inflammasome Gene Expression, and Pro-IL-1β Biosynthesis

2021 · Mansour A. Dughbaj, Jordanna G. Jayne, et al. · Antibiotics · 9

PDF

Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria

2021 · Eliford Kitabi, Timothy J Bensman, et al. · Clinical Infectious Diseases · 9

PDF

Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development

2023 · Caroline J Jjingo, Shukal Bala, et al. · Clinical Infectious Diseases · 8

A metagenomic analysis for combination therapy of multiple classes of antibiotics on the prevention of the spread of antibiotic-resistant genes

2023 · Matthew Igo, Lei Xu, et al. · Gut Microbes · 5

Pharmacokinetics of Tedizolid in Adults with Cystic Fibrosis

2017 · Joshua Wang, Jenny Park, et al. · Open Forum Infectious Diseases · 3

PDF

Reply to White et al

2022 · Eliford Kitabi, Timothy J Bensman, et al. · Clinical Infectious Diseases · 1

Semimechanistic Modeling of Eravacycline Pharmacodynamics Using In Vitro Time-Kill Data with MIC Incorporated in an Adaptive Resistance Function

2020 · Ken Nguyen, Timothy J. Bensman, et al. · Antimicrobial Agents and Chemotherapy · 1

WS7.2 Antibacterial activity of theta defensin (RTD-1) against clinical isolates of Pseudomonas aeruginosa

2014 · P. Beringer, H. Ho, et al. · Journal of Cystic Fibrosis · 1

PDF

175 Pharmacokinetics of ceftazidime-avibactam in adults with CF

2017 · P. Beringer, T. Bensman, et al. · Journal of Cystic Fibrosis

PDF

The Role of NOD-Mediated Innate Immune Activation in Lung Epithelia

2007 · Timothy J. Bensman · The Knowledge Bank (The Ohio State University)

PDF

Works count: 22

Citation count: 407

H-index: 11

I10-index: 11